Evaluating the Efficacy of Interferon Preparations in the Treatment of Acute Respiratory Viral Infections in Sickly Children
Journal Title: Здоров`я дитини - Year 2015, Vol 2, Issue 61
Abstract
The article presents the main approaches to the treatment and prevention of acute respiratory viral infections in sickly children. The analysis of our own researches on the efficacy of recombinant interferon alpha (Nazoferon) in the treatment of acute respiratory viral infections in these children has been carried out. The feasibility of adding this drug in the therapeutic complex has been proved.
Authors and Affiliations
L. V. Besh
Abdominal fat index — a non-invasive marker of hepatic steatosis and insulin resistance in children
Background. Elevation of visceral fat (VF) thickness is considered as a risk factor for non-alcoholic fatty liver disease in children. Non-invasive methods for evaluating the type of fat distribution allow to obtain usef...
Child health status — the future of the country (part 2)
The article deals with the problems of increasing the incidence and prevalence of childhood diseases during 1994–2016 against the background of a global reduction in the staffing of children’s specialists by 1.7 times, w...
Trigger Factors of Childhood in Development of Psoriasis
The article deals with identification of trigger factors of childhood that contributes to the occurrence and determines features of the clinical course of psoriasis. We have carried out survey of 520 patients with psoria...
Comparative Analysis of the State of Hepatobiliary System in Children Who Live in the Regions Polluted with Different Types of Xenobiotics
It has been carried out a comparative analysis of sonographic and biochemical parameters of the hepatobiliary system state in 63 children living in environmentally unfriendly regions with different route of xenoiotic ent...
Etiopathogenetic Therapy of Acute Respiratory Viral Infections in Children
The methods of etiopathogenetic treatment of acute respiratory viral infections in children using recombinant α-2b-interferons are presented in the article.